Evidence map›Paper›PMID 39659632›Full record

ArticleCirculation reports2024

Identification of Physician Concerns Regarding Implementation of the Nagasaki Acute Myocardial Infarction Secondary Prevention Clinical Pathway.

Masaya Kurobe, Yosuke Yamanaka, Akihito Uda, Katsuya Mori, Takeshi Akiyama, Ayumi Morishita, Yuta Ishikawa, Louis P Watanabe, Satoshi Ikeda, Koji Maemura

Abstract read
In one paragraph

Article in Circulation reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masaya KurobeDepartment of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Yosuke YamanakaHEOR Group, Value and Access Division, Novartis Pharma K.K. Tokyo Japan.
Akihito UdaHEOR Group, Value and Access Division, Novartis Pharma K.K. Tokyo Japan.
Katsuya MoriHEOR Group, Value and Access Division, Novartis Pharma K.K. Tokyo Japan.
Takeshi AkiyamaReal World Evidence Solutions & HEOR, IQVIA Solutions Japan G.K. Tokyo Japan.
Ayumi MorishitaReal World Evidence Solutions & HEOR, IQVIA Solutions Japan G.K. Tokyo Japan.
Yuta IshikawaReal World Evidence Solutions & HEOR, IQVIA Solutions Japan G.K. Tokyo Japan.
Louis P WatanabeReal World Evidence Solutions & HEOR, IQVIA Solutions Japan G.K. Tokyo Japan.
Satoshi IkedaStroke and Cardiovascular Diseases Support Center, Nagasaki University Hospital Nagasaki Japan.
Koji MaemuraDepartment of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Nagasaki Acute Myocardial Infarction Secondary Prevention Clinical Pathway (NASP) is a regional pathway that aims to standardize practices related to the treatment of acute myocardial infarction in order to improve patient prognoses. This study aimed to understand physician backgrounds and concerns regarding implementation of the NASP. Methods and Results: This exploratory sequential mixed-methods study was developed around the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework. Following focus group interviews, the web-based, self-administered questionnaire survey with a cross-sectional study design was given to 62 physicians who practiced at acute care hospitals (ACHs), primary care hospitals (PCHs), or outpatient clinics (OCs) in the Nagasaki prefecture. Hayashi's quantitative theory type II analysis was used to assess the quantitative relationship between physician characteristics and their concerns. In addition, physicians were clustered based on the types of concerns they had. Our results demonstrated that specialists in cardiovascular disease held more concerns regarding implementation of the NASP. Furthermore, workload burden was found to be the most common concern among these physicians. Cooperation between physicians at ACHs and physicians at PCHs/OCs was also found to be vital for the NASP. Conclusions: Interventions such as modifications to the NASP operation may assist in alleviating concerns regarding the NASP and allow for the development of tailored interventions and effective expansion of the pathway.

Indexed as

Clinical pathwayLipid managementMixed methodsRE-AIM frameworkSecondary prevention of acute myocardial infarction

Identifiers

PMID39659632
PMCPMC11628974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.